Antioxidant and Erythroprotective Effects of C-Phycocyanin from the Cyanobacterium Spirulina sp. in Attenuating Oxidative Stress Induced by Peroxyl Radicals
Authors:
- Cinthia Jael Gaxiola-CalvoCinthia Jael Gaxiola-Calvo
- Diana Fimbres-OlivarríaDiana Fimbres-Olivarría
- Ricardo Iván González-VegaRicardo Iván González-Vega
- Yaeel Isbeth Cornejo-RamírezYaeel Isbeth Cornejo-Ramírez
- Ariadna Thalía Bernal-MercadoAriadna Thalía Bernal-Mercado
- Saul Ruiz-CruzSaul Ruiz-Cruz
- José de Jesús Ornelas-PazJosé de Jesús Ornelas-Paz
- Miguel Ángel Robles-GarcíaMiguel Ángel Robles-García
- José Rogelio Ramos-EnríquezJosé Rogelio Ramos-Enríquez
- Carmen Lizette Del-Toro-SánchezCarmen Lizette Del-Toro-Sánchez
Preprint
- 5 December 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Blood groups in the ABO system and the RhD factor is of great clinical importance, as it is related to susceptibility to various diseases caused by oxidative stress. The use of antioxidants such as C-phycocyanin (a phycobiliprotein) could be an alternative to mit-igate oxidative stress in the blood. Therefore, the objective of this study is to evaluate the antioxidant and erythroprotective activity of C-phycocyanin (C-PC) from Spirulina sp. against oxidative stress caused by peroxyl radicals, before and after in vitro digestion, comparing susceptibilities between blood groups. C-phycocyanin from Spirulina sp. was obtained commercially. The antioxidant capacity by ABTS+•, DPPH•, and FRAP assays of the bioaccessible fraction of C-PC increased compared to baseline in all assays. Samples appear to have high hydrogen atom transfer. C-PC is not cytotoxic in most blood groups. The AAPH hemolysis assays showed differences between blood groups, yielding results of 27.90, 22.60, 26.94, 27.66, 28.16, 28.34, and 24.91% hemolysis for O+, O-, A+, A-, B+, AB+, and AB-, respectively. Furthermore, in vitro digestion increased the erythropro-tective effect in the bioavailable fraction in most blood groups, showing 37.12, 80.13, 5.48, 92.38, 67.93, 80.30, and 76.49% inhibition of hemolysis in O+, O-, A+, A-, B+, AB+, and AB-, respectively. These results demonstrate the biotechnological and biomedical po-tential of phycobiliproteins as safe candidates for the development of nutraceuticals and functional foods aimed at preventing oxidative damage.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?Medicine, 2023
- ABO blood group and Rh factor distributions in patients with epilepsyEpilepsy & Behavior, 2022
- Mode of action and determination of antioxidant activity in the dietary sources: An overviewSaudi Journal of Biological Sciences, 2021
- Relationship between the ABO Blood Group and the COVID-19 SusceptibilitymedRxiv, 2020
- Phycobiliproteins: Molecular structure, production, applications, and prospectsBiotechnology Advances, 2019
- Clinical Potential of Spirulina as a Source of PhycocyanobilinJournal of Medicinal Food, 2007
- Modified 2,2-Azino-bis-3-ethylbenzothiazoline-6-sulfonic Acid (ABTS) Method to Measure Antioxidant Capacity of Selected Small Fruits and Comparison to Ferric Reducing Antioxidant Power (FRAP) and 2,2‘-Diphenyl-1-picrylhydrazyl (DPPH) MethodsJournal of Agricultural and Food Chemistry, 2006
- Antioxidant activity applying an improved ABTS radical cation decolorization assayFree Radical Biology and Medicine, 1999
- The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP AssayAnalytical Biochemistry, 1996
- Use of a free radical method to evaluate antioxidant activityLWT, 1995